A Study of Two Different Formulations of LY3209590 in Healthy Participants
NCT04768842
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY3209590
Sponsor
Eli Lilly and Company